Key Takeaways
- Steady quarter with one-off tailwinds: Equity AUM grew +22.4% YoY, two-thirds from net sales and the Indus acquisition, while mutual fund revenue got a INR1.4 crores one-time lift from KYC-related brokerage release.
- Insurance revenue hit by GST reset: Premium grew 13% sequentially but revenue grew only 3.6% as health insurers cut rates ~18% after GST moved to nil, a structural yield compression that is now largely absorbed.
- TER circular is a strategic win, not a revenue one: SEBI’s move to make expense ratios exclusive of GST levels the playing field between GST-registered and unregistered distributors, which management expects to accelerate MFD onboarding onto Prudent’s platform.
- Indus integration is on track and margin-accretive: The acquisition improved the direct-to-regular mix by ~1%, pulling the commission payout ratio visibly lower, and client retention meetings have gone well.
- What to watch next quarter: Whether AMCs actually pass on the TER cut to distributors, the post-April life insurance GST arrangement that remains unnegotiated, and any SIP termination uptick if the market correction persists.
AUM Growth & Flow Dynamics
- Equity AUM engine: 22.4% YoY growth split roughly two-thirds from net sales and Indus, one-third from mark-to-market. Sequential growth of 6.9% came from MTM gains plus net sales of INR3,444 crores.
- SIP ambition intact: The company aims to cross INR1,200 crores in monthly SIP flows by March 2026. SIP market share in the regular plan segment has strengthened by 18–20 bps over the last year, even as direct plans grew faster industry-wide and compressed the headline market share number.
- Correction risk is acknowledged but not yet visible: If the current market correction continues for a few more months, management expects higher SIP termination and lower new registration. As of now, termination is not alarming even after the January/February drawdown. Lump-sum flows, which historically pick up on corrections, look unlikely in February given the prolonged negative sentiment.
- Direct-plan share context: Direct SIPs are ~35% of the total industry book, with the incremental flow share running higher. Management argues that maintaining headline market share in an environment where direct plans outgrow regular plans would itself signal a strengthened regular-plan position.
Revenue Yield & Regulatory Resets
- TER circular: SEBI now requires expense ratios to be exclusive of all statutory levies including GST. Management views this as revenue-neutral for GST-registered distributors but strategically beneficial: it removes the anomaly where unregistered distributors earned 18% more, improving Prudent’s competitiveness in attracting smaller MFDs.
- TER cut pass-through expectation: Top 5 AMCs, representing ~50% of AUM, are expected to pass on some commission cut to distributors. Management is confident it can pass that cut through to its own distributors proportionally, preserving net yield margins. No AMC has formally communicated a cut yet; clarity is expected by mid-March.
- Exit load benefit withdrawn: The 5 bps benefit available in lieu of exit load since 2012 has been removed. The exact sharing mechanism between AMC, distributor and other stakeholders will be known by April 2026.
- GST commission structure change (April 1): From April, all commission rates will be exclusive of GST for all distributors. Non-GST MFDs who previously received commission inclusive of GST will now get x minus 18%, which improves Prudent’s margin or competitiveness on those partners.
Shirish Patel: “From 1st of April, all the commission rates would be exclusive of GST. Whether the person is under GST or not under GST, the commission rate will be exclusive of GST. So earlier, the person -- non-GST person used to get x commission. From April, on the same business, he will get x minus 18%. So, by default, the competitiveness or the margins of Prudent on that particular partner or that particular MFD will increase.”
Insurance: The Yield Compression Story
- Health insurance rate rationalization: Premium grew 13% sequentially but revenue grew only 3.6%, driven by most health insurers reducing rates by ~18% from October 1 following the GST reduction to nil. This is a structural reset, not a demand issue.
- Life insurance GST renegotiation: In December, Prudent renegotiated the GST cut with life insurers, reducing the impact from ~30% (mentioned last quarter) to less than 10%. This arrangement is only until March 2026; no discussion has taken place for post-April.
- Life insurance product-mix shift: Yield has also compressed because TULIP (Term + ULIP combined) is now the biggest-selling product and carries a lower yield than traditional plans. ULIP, historically not sold, now has a higher single-digit market share.
Shirish Patel: “In the month of December, we could renegotiate that cut with the same manufacturer. So as of now, I think at least till March, the cut in the GST component from the life insurance business is not even 30%. I think it will be less than 10% now.”
Indus Acquisition & M&A Strategy
- Integration progressing well: Two meetings completed with all large Indus clients, with significant comfort on the integration. The acquisition is highly cash-accretive, powered by 15 experienced relationship managers under a seasoned business head.
- Payout ratio benefit: The commission payout ratio appeared lower than normal because Indus improved the direct-to-regular mix by ~1%. Indus carries an average payout ratio of ~1.2%, and roughly 60% of that improvement (70–80 bps) is visible in the reduced consolidated payout ratio.
- Finance cost mechanics: The INR92.32 lakh increase in finance cost reflects accounting treatment of deferred consideration payable to Indus capital, recognized at discounted present value with periodic interest accretion. This will recur every quarter for the next 11 quarters until full payment.
- M&A appetite remains: Given the successful Indus integration, Prudent is looking for similar opportunities where distributors seek alignment with scale and technology-driven platforms. The treasury corpus of INR537 crores provides a war chest, though nothing is concrete currently.
Non-MF Products & New Initiatives
- P2P replaced, PMS and FD growing: Revenue from P2P lending has fallen to almost zero but has been replaced by growth in PMS (book increasing steadily), fixed deposits (momentum picking up), and loans against mutual funds (~INR300 crores book). Broking, now merged into Prudent Corporate, is expected to contribute going forward but is not yet visible in revenue.
- SIF launch: The Specialized Investment Fund, categorized under mutual funds, is a new product in the kitty that management expects to become a very large product line.
- No forward revenue guidance: Management provided current product mix details but declined to give a forward run-rate trajectory for the non-MF non-insurance revenue line, which currently runs at INR8–9 crores.
Margins & Cost Structure
- Operating profit grew 7.8% sequentially despite two one-off cost items: an employee cost provision of INR1.49 crores related to the new labor code, and an ESOP charge of INR1.61 crores. The ESOP charge will repeat at the same level for the next three quarters (~INR7.2 crores annualized).
- Depreciation benefit: The useful life of Karvy-acquired assets was revised from 10 to 15 years based on operating experience, reducing amortization by INR1.7 crores for the quarter. Indus acquisition cost will also be amortized over 15 years. Net depreciation modestly increased from INR7.7 crores to INR8 crores.
- Other income tailwind: Other income grew 16.4% sequentially despite INR87.3 crores deployed from treasury for the Indus acquisition, supported by positive mark-to-market on the equity treasury as the Nifty50 rose 7%.
- One-off brokerage release: INR1.4 crores was released because SEBI allowed one KYC requirement to be waived for existing AMCs, converting certain accounts from “hold” to “register” status. ~50% related to Karvy customer KYC (not owned by any MFD) and was retained by Prudent; the other 50% will be shared with respective MFDs.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Monthly SIP flow target | Cross INR1,200 crores | By March 2026 |
| ESOP charge | INR1.61 crores per quarter (~INR7.2 crores annualized) | Next 3 quarters |
| Finance cost (Indus deferred consideration) | INR92.32 lakh per quarter interest accretion | Next 11 quarters |
| Life insurance GST arrangement | Impact contained to less than 10% | Until March 2026 (post-April unknown) |
| TER cut pass-through | Confident of passing on AMC cuts to distributors at least in percentage sharing ratio | Subject to AMC decisions (clarity expected mid-March) |
| MFD onboarding pace | Consistent with last year’s ~4,700–4,800 additions | Ongoing |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Revenue from operations | 7.3% sequential growth, 16.6% higher on a 9-month basis |
| Mutual fund revenue | 8.2% sequential growth, includes INR1.4 cr one-off from KYC-related brokerage release |
| Insurance revenue | 3.6% sequential growth, slower than 13% premium growth due to health insurance rate rationalization post-GST change |
| Operating profit | 7.8% sequential growth, 12.2% higher on a 9-month basis |
| Net profit | ₹57.6 cr, up 7.6% QoQ and 19.6% YoY; 9-month net profit at ₹162.9 cr, up 13.2% |
| Quarterly average AUM | ₹127,600 cr, up 21% YoY and 7.2% QoQ |
| Equity AUM | ₹125,700 cr as of Dec '25, up 22.4% YoY and 6.9% QoQ; net sales of ₹3,444 cr during the quarter |
| Monthly SIP book | ₹1,135 cr as of Dec '25, grown to ₹1,170 cr by late Jan '26; added ~₹200 cr over last 12 months |
| SIP market share | 3.5% as of Dec '25, improved 20 bps from 3.3% in Dec '24 |
| Treasury corpus | ₹537 cr, after utilizing ₹87.3 cr for Indus Capital acquisition |
| Other income | 16.4% sequential growth, driven by mark-to-market gains on equity treasury investments |
| Operating expenses | 7.2% sequential growth, includes one-off provision of ₹1.49 cr for new labour code and ESOP charge of ₹1.61 cr |
| Depreciation | ₹8 cr, modestly up from ₹7.7 cr; Karvy depreciation reduced by ₹1.7 cr after useful life revision to 15 years |
| Finance cost | ₹92.32 lakh increase, attributable to interest accretion on deferred consideration for Indus Capital; to continue for next 11 quarters |
| Employees | 1,539 as of 31st December 2025 |